M. McIlraith

1.5k citations
18 papers · 670 · 1 hit paper · h-index 7

Impact in

  • Immunology top 10%
    • Psoriasis: Treatment and Pathogenesis
    • T-cell and B-cell Immunology
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses
    • Rheumatoid Arthritis Research and Therapies
    • Spondyloarthritis Studies and Treatments

Papers in

    • Rheumatoid Arthritis Research and Therapies 7
    • Spondyloarthritis Studies and Treatments 5
    • T-cell and B-cell Immunology 5
    • Immunotherapy and Immune Responses 4
    • Psoriasis: Treatment and Pathogenesis 4
    • Immune Cell Function and Interaction 3

M. McIlraith

18 papers receiving 653 citations

M. McIlraith's Hit Papers

Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease 2012 · 433 citations
4330+4+9Years since publication100200300400

Peers

M. McIlraith
Comparison fields: 5 of 72
  • Immunology 362
  • Rheumatology 225
  • Hematology 130
  • Dermatology 78
  • Genetics 49
Replace Animesh Singh with:
Animesh Singh United Kingdom
M. Hirakata Japan
Paul D. Doodes United States
Gale A. McCarty United States
W E Ollier United Kingdom
Makio Kusaoi Japan
Catharina Schuetz Germany
Kazuki Tanimoto Japan
Carrie A. Fletcher Australia
Rudolf Mierau Germany
M. McIlraith relative to Animesh Singh United Kingdom Animesh Singh's profile →
Citations per field
00.5×
Animesh Singh · 1×
Citations per year

Countries citing papers authored by M. McIlraith

Since Specialization
Citations

This map shows the geographic impact of M. McIlraith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. McIlraith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. McIlraith more than expected).

Fields of papers citing papers by M. McIlraith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. McIlraith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. McIlraith. The network helps show where M. McIlraith may publish in the future.

Co-authors

The 25 scholars most cited alongside M. McIlraith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. McIlraith Line = papers co-authored together M. McIlraith links everyone, so they are left out of the graph.

All Works

18 of 18 papers shown
#Work
1
Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease
Hit paper breakdown →
2012433
2 199274
3 199773
4 199734
5 201212
6 19989
7 20157
8 19946
9
Initial Combination Therapy with Adalimumab Plus Methotrexate Leads to Better Long-Term Outcomes Than with Either Monotherapy in Patients with Early Rheumatoid Arthritis: 8-Year Results of An Open-Label Extension of a Phase 3 Trial
20115
10 20084
11 20174
12 20252
13 20172
14 20171
15 20081
16 20161
17 20161
18 20171

About M. McIlraith

M. McIlraith is a scholar working on Rheumatology, Immunology, Hematology, Genetics and Surgery, having authored 18 papers that have together received 670 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (7 papers), Spondyloarthritis Studies and Treatments (5 papers), T-cell and B-cell Immunology (5 papers), Immunotherapy and Immune Responses (4 papers), Psoriasis: Treatment and Pathogenesis (4 papers), Autoimmune and Inflammatory Disorders Research (4 papers), Inflammatory Bowel Disease (3 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Immunology (362 citations), Rheumatology (225 citations), Hematology (130 citations), Dermatology (78 citations) and Genetics (49 citations). M. McIlraith has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Remo Panaccione, Ana P. Lacerda, Kenneth B. Gordon, Gerd R Burmester, Peter E. Lipsky, Ranjeny Thomas, Laurie S. Davis, J F Attrep, Amrie C. Grammer and Yasunori Shimaoka. Their work appears in journals such as Annals of the Rheumatic Diseases, The Journal of Immunology, Lara D. Veeken, Cell Transplantation and Annals of the New York Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact